Carmichael Hill & Associates, Inc. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 101 filers reported holding SEELOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Carmichael Hill & Associates, Inc. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,704
-77.3%
31,000
+47.6%
0.00%
-72.7%
Q2 2023$25,095
+72.9%
21,0000.0%0.01%
+57.1%
Q1 2023$14,516
+94.3%
21,000
+90.9%
0.01%
+75.0%
Q4 2022$7,469
-32.1%
11,0000.0%0.00%
-33.3%
Q3 2022$11,000
+83.3%
11,000
+22.2%
0.01%
+100.0%
Q2 2022$6,000
+20.0%
9,000
+50.0%
0.00%
+50.0%
Q1 2022$5,000
-16.7%
6,000
+71.4%
0.00%
-33.3%
Q4 2021$6,000
+20.0%
3,500
+75.0%
0.00%
+50.0%
Q3 2021$5,0002,0000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders